Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy-Reference-Cited by-同舟云学术

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy

Published:2016-10-15 Issue:4 Volume:48 Page:1264-1273
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Park Inkeun,Choi Seung Joon,Kim Young Saing,Ahn Hee Kyung,Hong Junshik,Sym Sun Jin,Park Jinny,Cho Eun Kyung,Lee Jae Hoon,Shin Yong Ju,Shin Dong Bok

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2015-250.pdf

Reference28 articles.

1. Global cancer statistics, 2012

2. Pancreatic Cancer

3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

4. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2024-07

2. Body composition measures as a determinant of Alpelisib related toxicity;Breast Cancer Research and Treatment;2024-04-07

3. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer—a retrospective multicenter study;ESMO Open;2024-01

4. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

5. Sarkopenie als unabhängiger Prognosefaktor bei Pankreaskarzinom;TumorDiagnostik & Therapie;2023-11-28